
Pascal Vranckx
Declaration of interest
Function | Company |
---|---|
None |
Latest contributions
Clinical impact of mechanical circulatory support
22 May 2025 – From EuroPCR 2025
Explore the clinical impact of mechanical circulatory support through a series of detailed presentations covering protocols and training effects on outcomes in left-sided micro-axial flow-supported shock patients, practice variations between Sweden and the U.S., six-month outcomes post coronary intervention with VA-ECMO, and the prognostic value of...

ACS - Abstract session
19 May 2023 – From EuroPCR 2023
Looking for a quick review of the Abstract session on acute coronary syndrome (ACS)? Explore the presentation slides available here and catch up on key elements to consider.

Abbreviated DAPT after complex PCI in high bleeding risk patients
18 May 2022 – From EuroPCR 2022
Luis Ortega Paz interviews Pascal Vranckx on the background, main results and take-home messages from the sub-analysis of the MASTER DAPT study.

EuroPCR 2022 Hotlines / Late-Breaking Trials in coronary artery disease: MASTER DAPT, CRUZ-HBR, DISCO RADIAL, and more!
17 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in coronary artery disease! Abbreviated DAPT after complex PCI in high bleeding risk patients, comparing conventional and haemostatic dressings in radial access, angio-based QFR virtual PCI vs. conventional angio-guided PCI, CRUZ-HBR, CT-guided invasive coronary angiography in patients with...

ENTRUST-AF PCI - Edoxaban-based versus vitamin-K-antagonist-based antithrombotic regimen following successful coronary stenting in atrial fibrillation patients
09 Sep 2019
Francesco Costa, Italy, interviews Pascal Vranckx, PI of the ENTRUST-AF-PCI Trial

Controversies and future perspectives of antithrombotic therapy in atrial fibrillation patients undergoing coronary and valvular transcatheter interventions
23 May 2019 – From EuroPCR 2019
Consult this session to learn about the updated perspective on the bleeding definition in interventional cardiology, and antithrombotic treatment regimens in atrial fibrillation patients undergoing PCI or TAVI.

Mechanical circulatory support in cardiogenic shock
23 May 2019 – From EuroPCR 2019
Consult this session to learn all about mechanical circulatory support in cardiogenic shock: how to select the right circulatory support, how to organise the shock team, and more!

Pharmacotherapy before/during/after PCI
21 May 2019 – From EuroPCR 2019
Consult this session to learn all about pharmacotherapy before / during / after PCI, and discover the results of various studies and trials: GLOBAL LEADERS, DUAL PCI, MATRIX, and more!

Drugs and Devices Synergy : PCR clinical algorithms
15 May 2018
Access the leading specialists’ practical and brief algorithms - put on line following each of four dedicated case-based sessions at EuroPCR
